Integumentary system and skin and mucous membranes and subcutaneous tissues, percutaneous approach

17 items in this category

• 85813504Introduction of analgesics, hypnotics, sedatives into subcutaneous tissue, percutaneous approach
  Exempt
• 85813513Introduction of anti-infective envelope into subcutaneous tissue, percutaneous approach
  Exempt
• 85813512Introduction of anti-inflammatory into subcutaneous tissue, percutaneous approach
  Exempt
• 85813503Introduction of destructive agent into subcutaneous tissue, percutaneous approach
  Exempt
• 85813509Introduction of electrolytic and water balance substance into subcutaneous tissue, percutaneous approach
  Exempt
• 85813502Introduction of insulin into subcutaneous tissue, percutaneous approach
  Exempt
• 85813508Introduction of local anesthetic into subcutaneous tissue, percutaneous approach
  Exempt
• 85813516Introduction of monoclonal antibody into subcutaneous tissue, percutaneous approach
  Exempt
• 85813510Introduction of nutritional substance into subcutaneous tissue, percutaneous approach
  Exempt
• 85813514Introduction of other anti-infective into subcutaneous tissue, percutaneous approach
  Exempt
• 85813517Introduction of other antineoplastic into subcutaneous tissue, percutaneous approach
  Exempt
• 85813505Introduction of other diagnostic substance into subcutaneous tissue, percutaneous approach
  Exempt
• 85813501Introduction of other hormone into subcutaneous tissue, percutaneous approach
  Exempt
• 85813507Introduction of other therapeutic substance into subcutaneous tissue, percutaneous approach
  Exempt
• 85813515Introduction of oxazolidinones into subcutaneous tissue, percutaneous approach
  Exempt
• 85813506Introduction of radioactive substance into subcutaneous tissue, percutaneous approach
  Exempt
• 85813511Introduction of serum, toxoid and vaccine into subcutaneous tissue, percutaneous approach
  Exempt